Using Real-world Data to Assess the Burden of Diabetes in Children and Adolescents in Florida
Using Real-world Data to Assess the Burden of Diabetes in Children and Adolescents in Florida
批准号:
10636657
负责人:
Jiang Bian
金额:
$25.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-30 至 2025-09-29
中文摘要
摘要
强有力的证据表明,1型和2型糖尿病(T1 DM &
自2000年以来,美国(US)和全球儿童和青少年中的T2 DM。重要的种族-
在糖尿病发病率和获得护理方面也有种族和地理差异,
代谢控制在这个脆弱的群体。这些令人震惊的观察需要及时监测
儿童和青少年糖尿病发病的系统,以便量身定制的公共卫生计划,
发展和卫生保健资源可以有效地分配,以满足这些弱势群体的需要,
组及时。然而,对这一特定人群的糖尿病监测研究有限,
美方目前儿童糖尿病患病率和发病率估计的主要来源,
美国疾病预防控制中心的青少年糖尿病研究来自青少年糖尿病研究,该研究依赖于
来自十个州的注册临床中心的活跃病例报告系统。这项研究是
然而,重要的是不包括东南地区的大多数人口,
发现糖尿病患病率在该国成年人口中是最高的(即,糖尿病
皮带”)。我们对该地区儿童和青少年糖尿病的患病率和发病率知之甚少,
包括佛罗里达在内的其他州也是全国最高的。
在这项拟议的研究中,我们将在佛罗里达建立一个监测系统,以监测
儿童和青少年的糖尿病,以准确,具有成本效益和及时的方式。作为第三大
佛罗里达是美国人口众多的州,种族和地理差异很大,
作为国家糖尿病监测系统的重要组成部分,并提供重要的研究数据。
美国东南部地区儿童和青少年的糖尿病流行病学,
是全国最普遍的我们将利用我们独特的真实世界数据(RWD)源,
OneFlorida网络,一个大型的全州范围的RWD存储库,包含链接的EHR,索赔,重要统计数据,
和出生记录数据,覆盖所有67个佛罗里达县超过60%的佛罗里达人,
糖尿病监测系统特别是,我们将联合收割机结合结构化和非结构化数据(例如,
医生的笔记),以开发新的数据驱动的可计算表型(CP)算法
通过现代机器学习方法,使我们对T1 DM患病率和发病率的估计
和T2 DM将比先前的基于EHR的系统更准确。这项研究还将产生重要的数据
研究健康的社会和行为决定因素以及许多其他潜在的影响因素,
导致糖尿病的种族-种族和地理差异,在两个个体(例如,个人健康
行为)和上下文级别(例如,地区一级的代谢控制计划)。
英文摘要
ABSTRACT
Strong evidence suggests an increasing trend of diabetes onset for both type 1 and type 2 diabetes (T1DM &
T2DM) among children and adolescent in the United State (US) and globally since 2000. Significant racial-
ethnic and geographic disparities have also been documented in diabetes incidence and in access to care and
metabolic control in this vulnerable population. These alarming observations call for a timely surveillance
system for the onset of diabetes among children and adolescents, so that tailored public health programs can
be developed and health care resources can be efficiently allocated to address the needs of these vulnerable
groups in a timely manner. However, diabetes surveillance studies on this particular population are limited in
the US. The primary source for current prevalence and incidence estimates of diabetes among children and
adolescents in the US for the CDC is from the SEARCH for Diabetes in Youth (SEARCH) study, which relies
on an active case reporting system from enrolled clinical centers over ten states. The SEARCH study is
important, however, does not include the majority of the population located at the south-east region, where
diabetes prevalence was found to be the highest in the country among the adult population (i.e., the “diabetes
belt”). Less is known if the prevalence and incidence of diabetes among children and adolescents in this area,
including Florida, are also the highest in the country.
In this proposed study, we will build a surveillance system in Florida to monitor the prevalence and incidence of
diabetes among children and adolescents in an accurate, cost-effective, and timely fashion. As the 3rd-most
populous state in the United States with a high level of racial-ethnical and geographic diversities, Florida will
serve as an essential piece for the national diabetes surveillance system and provide important data to study
the diabetes epidemiology among children and adolescents in the south-east region of the US where diabetes
was found the most prevalent in the country. We will leverage our unique real-world data (RWD) source, the
OneFlorida network, a large state-wide repository of RWD that contains linked EHRs, claims, vital statistics,
and birth records data, covering more than 60% of Floridians across all 67 Florida counties to build this
diabetes surveillance system. In particular, we will combine the structured and unstructured data (e.g.,
physician’s notes) from patients EHRs to develop novel data-driven computable phenotyping (CP) algorithms
through modern machine learning methods, so that our estimations on the prevalence and incidence of T1DM
and T2DM will be more accurate than prior EHRs-based systems. This study will also generate important data
to study the social and behavioral determinants of health among many other potential contributing factors that
results in ethnic-racial and geographic disparities of the diabetes, at both individual (e.g., individual health
behaviors) and contextual levels (e.g., area-level access to metabolic control programs).
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
The role of health system penetration rate in estimating the prevalence of type 1 diabetes in children and adolescents using electronic health records.
卫生系统普及率在使用电子健康记录估算儿童和青少年 1 型糖尿病患病率方面的作用。
DOI:
10.1093/jamia/ocad194
发表时间:
2023
期刊:
Journal of the American Medical Informatics Association : JAMIA
影响因子:
--
作者:
[Li,Piaopiao, Lyu,Tianchen, Alkhuzam,Khalid, Spector,Eliot, Donahoo,WilliamT, Bost,Sarah, Wu,Yonghui, Hogan,WilliamR, Prosperi,Mattia, Schatz,DesmondA, Atkinson,MarkA, Haller,MichaelJ, Shenkman,ElizabethA, Guo,Yi, Bian,Jiang, Shao,Hui]
通讯作者:
Shao,Hui
DOI:
10.1016/j.ijmedinf.2022.104804
发表时间:
2022-05
期刊:
International journal of medical informatics
影响因子:
4.9
作者:
[Yunpeng Zhao;Xing He;Zheng Feng;S. Bost;M. Prosperi;Yonghui Wu;Yi Guo;Jiang Bian]
通讯作者:
Yunpeng Zhao;Xing He;Zheng Feng;S. Bost;M. Prosperi;Yonghui Wu;Yi Guo;Jiang Bian
The diminishing cost-effectiveness of the newer glucose-lowering drug classes in the United States: 2010-2018.
美国新型降糖药物的成本效益递减:2010-2018 年。
DOI:
10.1080/03007995.2021.1971181
发表时间:
2021
期刊:
Current medical research and opinion
影响因子:
2.3
作者:
[Li,Piaopiao, Patel,Rahul, Guo,Jingchuan, Vouri,ScottM, Shi,Lizheng, Fonseca,Vivian, Shao,Hui]
通讯作者:
Shao,Hui
ACTS (AD Clinical Trial Simulation): Developing Advanced Informatics Approaches for an Alzheimer's Disease Clinical Trial Simulation System
-
批准号:10753675
-
项目类别:
-
资助金额:$115.53万
-
财政年份:2023
-
负责人:Jiang Bian
-
依托单位:
Disparities of Alzheimer's disease progression in sexual and gender minorities
-
批准号:10590413
-
项目类别:
-
资助金额:$80.96万
-
财政年份:2023
-
负责人:Jiang Bian
-
依托单位:
Post-Acute Sequelae of SARS-CoV-2 Infection and Subsequent Disease Progression in Individuals with AD/ADRD: Influence of the Social and Environmental Determinants of Health
-
批准号:10751275
-
项目类别:
-
资助金额:$256.15万
-
财政年份:2023
-
负责人:Jiang Bian
-
依托单位:
Artificial Intelligence and Counterfactually Actionable Responses to End HIV (AI-CARE-HIV)
-
批准号:10699171
-
项目类别:
-
资助金额:$73.14万
-
财政年份:2023
-
负责人:Jiang Bian
-
依托单位:
An end-to-end informatics framework to study Multiple Chronic Conditions (MCC)'s impact on Alzheimer's disease using harmonized electronic health records
-
批准号:10728800
-
项目类别:
-
资助金额:$116.82万
-
财政年份:2023
-
负责人:Jiang Bian
-
依托单位:
AI-ADRD: Accelerating interventions of AD/ADRD via Machine learning methods
-
批准号:10682237
-
项目类别:
-
资助金额:$234.89万
-
财政年份:2023
-
负责人:Jiang Bian
-
依托单位:
Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations (PLuS2)
-
批准号:10752848
-
项目类别:
-
资助金额:$55.65万
-
财政年份:2023
-
负责人:Jiang Bian
-
依托单位:
Eligibility criteria design for Alzheimer's trials with real-world data and explainable AI
-
批准号:10608470
-
项目类别:
-
资助金额:$82.02万
-
财政年份:2023
-
负责人:Jiang Bian
-
依托单位:
Computational Drug Repurposing for AD/ADRD with Integrative Analysis of Real World Data and Biomedical Knowledge
-
批准号:10576853
-
项目类别:
-
资助金额:$77.52万
-
财政年份:2022
-
负责人:Jiang Bian
-
依托单位:
Computational Drug Repurposing for AD/ADRD with Integrative Analysis of Real World Data and Biomedical Knowledge
-
批准号:10392169
-
项目类别:
-
资助金额:$80.75万
-
财政年份:2022
-
负责人:Jiang Bian
-
依托单位:
PANDA-MSD: Predictive Analytics via Networked Distributed Algorithms for Multi-System Diseases
-
批准号:10677539
-
项目类别:
-
资助金额:$119.57万
-
财政年份:2022
-
负责人:Jiang Bian
-
依托单位:
PANDA-MSD: Predictive Analytics via Networked Distributed Algorithms for Multi-System Diseases
-
批准号:10368562
-
项目类别:
-
资助金额:$121.22万
-
财政年份:2022
-
负责人:Jiang Bian
-
依托单位:
The External Exposome and COVID-19 Severity
-
批准号:10531662
-
项目类别:
-
资助金额:$23.27万
-
财政年份:2021
-
负责人:Jiang Bian
-
依托单位:
Advancing Drug Repositioning for Alzheimer’s Disease using Real-world Data
-
批准号:10374177
-
项目类别:
-
资助金额:$76.13万
-
财政年份:2021
-
负责人:Jiang Bian
-
依托单位:
Optimizing the Population Representativeness of Older Adults in Cancer Trials
-
批准号:10180066
-
项目类别:
-
资助金额:$39.21万
-
财政年份:2021
-
负责人:Jiang Bian
-
依托单位:
Advancing Drug Repositioning for Alzheimer’s Disease using Real-world Data
-
批准号:10330045
-
项目类别:
-
资助金额:$79.87万
-
财政年份:2021
-
负责人:Jiang Bian
-
依托单位:
The External Exposome and COVID-19 Severity
-
批准号:10174270
-
项目类别:
-
资助金额:$22.19万
-
财政年份:2020
-
负责人:Jiang Bian
-
依托单位:
Examine the risk of Alzheimer's disease in sexual and gender minorities
-
批准号:10283696
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2020
-
负责人:Jiang Bian
-
依托单位:
The benefits and harms of lung cancer screening in Florida
-
批准号:10576300
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2020
-
负责人:Jiang Bian
-
依托单位:
Optimizing Alzheimer's Disease Clinical Trial Generalizability
-
批准号:10091637
-
项目类别:
-
资助金额:$37.08万
-
财政年份:2020
-
负责人:Jiang Bian
-
依托单位:
国内基金
海外基金
高熵REAl3C3抗长时超高温氧化机理与熵效应的构效关系研究
-
批准号:52571090
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2025
-
负责人:赵国瑞
-
依托单位:
Immuno-Real Time PCR法精确定量血清MG7抗原及在早期胃癌预警中的价值
-
批准号:30600737
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2006
-
负责人:陈峥
-
依托单位:
无色ReAl3(BO3)4(Re=Y,Lu)系列晶体紫外倍频性能与器件研究
-
批准号:60608018
-
项目类别:青年科学基金项目
-
资助金额:28.0万元
-
批准年份:2006
-
负责人:叶宁
-
依托单位: